| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Audience (ADNC) | J.P. Morgan/ Credit Suisse/ Deutsche Bank Securities | $75.00 | n.a. | |||
| AVG Technologies N.V. (AVG) | Morgan Stanley/ J.P. Morgan/ Goldman, Sachs | $125.00 | n.a. | |||
| Cinco Resources (CINC) | Citigroup/ Wells Fargo Securities | $172.50 | n.a. | |||
| MRC Global (MRC) | tba | $100.00 | n.a. | |||
| RNK Global Development Acquisition (tba)(u) | Chardan Capital Markets, LLC | 3.75 | $10.00 | $10.00 | $37.50 | n.a. |
| Splunk (SPLK) | Morgan Stanley/ Credit Suisse/ J.P. Morgan/ BofA Merrill Lynch | $125.00 | n.a. | |||
| Sprott Physical Platinum and Palladium Trust (PPT.U) | Morgan Stanley/ RBC Capital Markets | 10.00 | $10.00 | $10.00 | $100.00 | n.a. |
| n.a. (not available) | ||||||
| tba (to be announced) | ||||||
| u (unit offering) | ||||||
| SCOOP Ratings From Previous Weeks | ||||||
| Extend Health (XH) | Morgan Stanley/ Barclays Capital | $75.00 | n.a. | |||
| Infoblox (BLOX) | Morgan Stanley/ Goldman, Sachs/ UBS Securities | $125.00 | n.a. | |||
| Millennial Media (tba) | Morgan Stanley/ Goldman, Sachs/ Barclays Capital | $75.00 | n.a. | |||
| Pacasmayo Cement (CPAC) | J.P. Morgan/ Santander | $250.00 | n.a. | |||
| Pacific Coast Oil Trust (ROYT) | Barclays Capital | $345.00 | n.a. | |||
| SandRidge Mississippian Trust II (SDR) | Morgan Stanley/ Raymond James | 25.00 | $603.75 | n.a. | ||
| Ute Energy (UTE) | Credit Suisse/ Goldman, Sachs & Co. | $250.00 | n.a. | |||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Carlyle Group L.P. (CG) | J.P. Morgan/ Citigroup/ Credit Suisse | $100.00 | 2-Stars | |||
| Cempra Holdings (CEMP) | Stifel Nicolaus Weisel/ Leerink Swann/ Cowen and Company | 6.00 | $11.00 | $13.00 | $72.00 | 1-Star |
| Guidewire Software (GWRE) | J.P. Morgan/ Deutsche Bank Securities/ Citigroup | 7.50 | $10.00 | $12.00 | $82.50 | 2-Stars |
| IntelePeer (PEER) | J.P. Morgan/ Deutsche Bank Securities/ Barclays Capital | 7.50 | $9.00 | $11.00 | $75.00 | 2-Stars |
| Merrimack Pharmaceuticals (MACK) | J.P. Morgan | 16.67 | $8.00 | $10.00 | $150.00 | 1-Star |
| Verastem (VSTM) | UBS Investment Bank/ Leerink Swann | 4.50 | $9.00 | $11.00 | $45.00 | 1-Star |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Weeks of Jan. 9, 2012 | Manager(s) | Offered | Raised | Price | 1/13/12 | Change |
| None | ||||||
